Our findings suggest that NR4A1 may regulate the protein expression of SERPINE1 by binding to it, and that inhibiting SERPINE1 can downregulate the invasion and infiltrative spread of glioma primary cells. Here, NR4A1 is linked to central nervous system cancer.